Bavituximab Completed Phase 1 Trials for Stage IV Breast Cancer / Human Epidermal Growth Factor 2 Negative Carcinoma of Breast / Male Breast Cancer / Stage IIIC Breast Cancer / HER2-Negative Breast Cancer / Recurrent Breast Cancer Treatment